首页> 外国专利> TREATMENT OF NEURODEGENERATIVE DISEASES WITH ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS AND COMPOSITIONS RELATED THERETO

TREATMENT OF NEURODEGENERATIVE DISEASES WITH ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS AND COMPOSITIONS RELATED THERETO

机译:芦荟素内切肽酶(AEP)抑制剂及其相关成分治疗神经退行性疾病

摘要

This disclosure relates to asparagine endopeptidase inhibitors and compositions and uses related thereto. In certain embodiments, the asparagine endopeptidase inhibitors are useful for treating or preventing neurodegenerative diseases and cognitive disorders such as Alzheimer's Disease. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising an asparagine endopeptidase inhibitor and a pharmaceutically acceptable excipient. In certain embodiments, the disclosure relates to methods of treating or preventing a neurodegenerative disease comprising administering an effective amount of pharmaceutical composition a asparagine endopeptidase inhibitor disclosed herein to a subject in need thereof.
机译:本公开涉及天冬酰胺内肽酶抑制剂和组合物以及与其相关的用途。在某些实施方案中,天冬酰胺内肽酶抑制剂可用于治疗或预防神经退行性疾病和认知障碍,例如阿尔茨海默氏病。在某些实施方案中,本公开涉及包含天冬酰胺内肽酶抑制剂和药学上可接受的赋形剂的药物组合物。在某些实施方案中,本公开涉及治疗或预防神经退行性疾病的方法,所述方法包括向有此需要的受试者施用有效量的本文公开的药物组合物天冬酰胺内肽酶抑制剂。

著录项

  • 公开/公告号EP3129361A1

    专利类型

  • 公开/公告日2017-02-15

    原文格式PDF

  • 申请/专利权人 EMORY UNIVERSITY;

    申请/专利号EP20150777056

  • 发明设计人 YE KEQIANG;FU HAIAN;DU YUHONG;

    申请日2015-04-08

  • 分类号C07D271/12;C07D285/14;A61K31/4245;A61K31/433;A61K9/20;A61K9/48;A61K47/38;

  • 国家 EP

  • 入库时间 2022-08-21 14:03:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号